The spectrum of movement disorders in Glut-1 deficiency.
Identifieur interne : 001553 ( PubMed/Checkpoint ); précédent : 001552; suivant : 001554The spectrum of movement disorders in Glut-1 deficiency.
Auteurs : Roser Pons [Grèce] ; Abbie Collins ; Michael Rotstein ; Kristin Engelstad ; Darryl C. De VivoSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2010.
English descriptors
- KwdEn :
- Adolescent, Adult, Child, Child, Preschool, Female, Gait Disorders, Neurologic (diet therapy), Gait Disorders, Neurologic (etiology), Gait Disorders, Neurologic (genetics), Glucose (cerebrospinal fluid), Glucose Metabolism Disorders (cerebrospinal fluid), Glucose Metabolism Disorders (complications), Glucose Metabolism Disorders (genetics), Glucose Transporter Type 1 (deficiency), Humans, Infant, Ketogenic Diet (methods), Longitudinal Studies, Male, Movement Disorders (classification), Movement Disorders (diet therapy), Movement Disorders (etiology), Movement Disorders (genetics), Severity of Illness Index, Stereotyped Behavior (physiology), Video Recording, Young Adult.
- MESH :
- chemical , cerebrospinal fluid : Glucose.
- cerebrospinal fluid : Glucose Metabolism Disorders.
- classification : Movement Disorders.
- complications : Glucose Metabolism Disorders.
- chemical , deficiency : Glucose Transporter Type 1.
- diet therapy : Gait Disorders, Neurologic, Movement Disorders.
- etiology : Gait Disorders, Neurologic, Movement Disorders.
- genetics : Gait Disorders, Neurologic, Glucose Metabolism Disorders, Movement Disorders.
- methods : Ketogenic Diet.
- physiology : Stereotyped Behavior.
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Longitudinal Studies, Male, Severity of Illness Index, Video Recording, Young Adult.
Abstract
To assess the spectrum of movement disorders, we reviewed video recordings and charts of 57 patients with Glut-1 deficiency. Eighty-nine percent of patients with Glut-1 deficiency syndrome had a disturbance of gait. The most frequent gait abnormalities were ataxic-spastic and ataxic. Action limb dystonia was observed in 86% of cases and mild chorea in 75%. Cerebellar action tremor was seen in 70% of patients, myoclonus in 16%, and dyspraxia in 21%. Nonepileptic paroxysmal events occurred in 28% of patients, and included episodes of ataxia, weakness, Parkinsonism and nonkinesogenic dyskinesias. The 40 patients (70%) who were on the ketogenic diet had less severe gait disturbances but more dystonia, chorea, tremor, myoclonus, dyspraxia, and paroxysmal events compared with the 17 patients on a conventional diet. Poor dietary compliance and low ketonuria appear to trigger the paroxysmal events in some patients. Gait disturbances and movement disorders are frequent in patients with Glut-1 deficiency and are signs of chronic and intermittent pyramidal, cerebellar and extrapyramidal circuit dysfunction. These clinical symptoms reflect chronic nutrient deficiency during brain development and may be mitigated by chronic ketosis.
DOI: 10.1002/mds.22808
PubMed: 20063428
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:20063428Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The spectrum of movement disorders in Glut-1 deficiency.</title>
<author><name sortKey="Pons, Roser" sort="Pons, Roser" uniqKey="Pons R" first="Roser" last="Pons">Roser Pons</name>
<affiliation wicri:level="1"><nlm:affiliation>Agia Sofia Hospital, First Department of Pediatrics, University of Athens, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Agia Sofia Hospital, First Department of Pediatrics, University of Athens, Athens</wicri:regionArea>
<wicri:noRegion>Athens</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Collins, Abbie" sort="Collins, Abbie" uniqKey="Collins A" first="Abbie" last="Collins">Abbie Collins</name>
</author>
<author><name sortKey="Rotstein, Michael" sort="Rotstein, Michael" uniqKey="Rotstein M" first="Michael" last="Rotstein">Michael Rotstein</name>
</author>
<author><name sortKey="Engelstad, Kristin" sort="Engelstad, Kristin" uniqKey="Engelstad K" first="Kristin" last="Engelstad">Kristin Engelstad</name>
</author>
<author><name sortKey="De Vivo, Darryl C" sort="De Vivo, Darryl C" uniqKey="De Vivo D" first="Darryl C" last="De Vivo">Darryl C. De Vivo</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.22808</idno>
<idno type="RBID">pubmed:20063428</idno>
<idno type="pmid">20063428</idno>
<idno type="wicri:Area/PubMed/Corpus">001A37</idno>
<idno type="wicri:Area/PubMed/Curation">001A37</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001553</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The spectrum of movement disorders in Glut-1 deficiency.</title>
<author><name sortKey="Pons, Roser" sort="Pons, Roser" uniqKey="Pons R" first="Roser" last="Pons">Roser Pons</name>
<affiliation wicri:level="1"><nlm:affiliation>Agia Sofia Hospital, First Department of Pediatrics, University of Athens, Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Agia Sofia Hospital, First Department of Pediatrics, University of Athens, Athens</wicri:regionArea>
<wicri:noRegion>Athens</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Collins, Abbie" sort="Collins, Abbie" uniqKey="Collins A" first="Abbie" last="Collins">Abbie Collins</name>
</author>
<author><name sortKey="Rotstein, Michael" sort="Rotstein, Michael" uniqKey="Rotstein M" first="Michael" last="Rotstein">Michael Rotstein</name>
</author>
<author><name sortKey="Engelstad, Kristin" sort="Engelstad, Kristin" uniqKey="Engelstad K" first="Kristin" last="Engelstad">Kristin Engelstad</name>
</author>
<author><name sortKey="De Vivo, Darryl C" sort="De Vivo, Darryl C" uniqKey="De Vivo D" first="Darryl C" last="De Vivo">Darryl C. De Vivo</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Gait Disorders, Neurologic (diet therapy)</term>
<term>Gait Disorders, Neurologic (etiology)</term>
<term>Gait Disorders, Neurologic (genetics)</term>
<term>Glucose (cerebrospinal fluid)</term>
<term>Glucose Metabolism Disorders (cerebrospinal fluid)</term>
<term>Glucose Metabolism Disorders (complications)</term>
<term>Glucose Metabolism Disorders (genetics)</term>
<term>Glucose Transporter Type 1 (deficiency)</term>
<term>Humans</term>
<term>Infant</term>
<term>Ketogenic Diet (methods)</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Movement Disorders (classification)</term>
<term>Movement Disorders (diet therapy)</term>
<term>Movement Disorders (etiology)</term>
<term>Movement Disorders (genetics)</term>
<term>Severity of Illness Index</term>
<term>Stereotyped Behavior (physiology)</term>
<term>Video Recording</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="cerebrospinal fluid" xml:lang="en"><term>Glucose</term>
</keywords>
<keywords scheme="MESH" qualifier="cerebrospinal fluid" xml:lang="en"><term>Glucose Metabolism Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Glucose Metabolism Disorders</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="deficiency" xml:lang="en"><term>Glucose Transporter Type 1</term>
</keywords>
<keywords scheme="MESH" qualifier="diet therapy" xml:lang="en"><term>Gait Disorders, Neurologic</term>
<term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Gait Disorders, Neurologic</term>
<term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Gait Disorders, Neurologic</term>
<term>Glucose Metabolism Disorders</term>
<term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Ketogenic Diet</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Stereotyped Behavior</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Severity of Illness Index</term>
<term>Video Recording</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To assess the spectrum of movement disorders, we reviewed video recordings and charts of 57 patients with Glut-1 deficiency. Eighty-nine percent of patients with Glut-1 deficiency syndrome had a disturbance of gait. The most frequent gait abnormalities were ataxic-spastic and ataxic. Action limb dystonia was observed in 86% of cases and mild chorea in 75%. Cerebellar action tremor was seen in 70% of patients, myoclonus in 16%, and dyspraxia in 21%. Nonepileptic paroxysmal events occurred in 28% of patients, and included episodes of ataxia, weakness, Parkinsonism and nonkinesogenic dyskinesias. The 40 patients (70%) who were on the ketogenic diet had less severe gait disturbances but more dystonia, chorea, tremor, myoclonus, dyspraxia, and paroxysmal events compared with the 17 patients on a conventional diet. Poor dietary compliance and low ketonuria appear to trigger the paroxysmal events in some patients. Gait disturbances and movement disorders are frequent in patients with Glut-1 deficiency and are signs of chronic and intermittent pyramidal, cerebellar and extrapyramidal circuit dysfunction. These clinical symptoms reflect chronic nutrient deficiency during brain development and may be mitigated by chronic ketosis.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">20063428</PMID>
<DateCreated><Year>2010</Year>
<Month>03</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>06</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>3</Issue>
<PubDate><Year>2010</Year>
<Month>Feb</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>The spectrum of movement disorders in Glut-1 deficiency.</ArticleTitle>
<Pagination><MedlinePgn>275-81</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.22808</ELocationID>
<Abstract><AbstractText>To assess the spectrum of movement disorders, we reviewed video recordings and charts of 57 patients with Glut-1 deficiency. Eighty-nine percent of patients with Glut-1 deficiency syndrome had a disturbance of gait. The most frequent gait abnormalities were ataxic-spastic and ataxic. Action limb dystonia was observed in 86% of cases and mild chorea in 75%. Cerebellar action tremor was seen in 70% of patients, myoclonus in 16%, and dyspraxia in 21%. Nonepileptic paroxysmal events occurred in 28% of patients, and included episodes of ataxia, weakness, Parkinsonism and nonkinesogenic dyskinesias. The 40 patients (70%) who were on the ketogenic diet had less severe gait disturbances but more dystonia, chorea, tremor, myoclonus, dyspraxia, and paroxysmal events compared with the 17 patients on a conventional diet. Poor dietary compliance and low ketonuria appear to trigger the paroxysmal events in some patients. Gait disturbances and movement disorders are frequent in patients with Glut-1 deficiency and are signs of chronic and intermittent pyramidal, cerebellar and extrapyramidal circuit dysfunction. These clinical symptoms reflect chronic nutrient deficiency during brain development and may be mitigated by chronic ketosis.</AbstractText>
<CopyrightInformation>(c) 2009 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pons</LastName>
<ForeName>Roser</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Agia Sofia Hospital, First Department of Pediatrics, University of Athens, Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Collins</LastName>
<ForeName>Abbie</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rotstein</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Engelstad</LastName>
<ForeName>Kristin</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>De Vivo</LastName>
<ForeName>Darryl C</ForeName>
<Initials>DC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>1 UL1 RR024156-01</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>NS37949</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051272">Glucose Transporter Type 1</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber>
<NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020233">Gait Disorders, Neurologic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005947">Glucose</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000134">cerebrospinal fluid</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D044882">Glucose Metabolism Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000134">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D051272">Glucose Transporter Type 1</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000172">deficiency</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D055423">Ketogenic Diet</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008137">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009069">Movement Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000145">classification</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000178">diet therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013239">Stereotyped Behavior</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014741">Video Recording</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>1</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>1</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>6</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.22808</ArticleId>
<ArticleId IdType="pubmed">20063428</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Grèce</li>
</country>
</list>
<tree><noCountry><name sortKey="Collins, Abbie" sort="Collins, Abbie" uniqKey="Collins A" first="Abbie" last="Collins">Abbie Collins</name>
<name sortKey="De Vivo, Darryl C" sort="De Vivo, Darryl C" uniqKey="De Vivo D" first="Darryl C" last="De Vivo">Darryl C. De Vivo</name>
<name sortKey="Engelstad, Kristin" sort="Engelstad, Kristin" uniqKey="Engelstad K" first="Kristin" last="Engelstad">Kristin Engelstad</name>
<name sortKey="Rotstein, Michael" sort="Rotstein, Michael" uniqKey="Rotstein M" first="Michael" last="Rotstein">Michael Rotstein</name>
</noCountry>
<country name="Grèce"><noRegion><name sortKey="Pons, Roser" sort="Pons, Roser" uniqKey="Pons R" first="Roser" last="Pons">Roser Pons</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001553 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001553 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:20063428 |texte= The spectrum of movement disorders in Glut-1 deficiency. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:20063428" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |